Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Fri, Mar 21, 2025
[Archive]
Volume 13, Issue 2 (Spring 2022)
Caspian J Intern Med 2022, 13(2): 311-325 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tavassoli M, Jokar R, Zamani M, Khafri S, Esmaeilnejad-Ganji S M. Clinical efficacy of local injection therapies for lateral epicondylitis: A systematic review and network meta-analysis. Caspian J Intern Med 2022; 13 (2) :311-325
URL: http://caspjim.com/article-1-2904-en.html
URL: http://caspjim.com/article-1-2904-en.html
Mehdi Tavassoli 
, Rahmatollah Jokar , Mohammad Zamani , Soraya Khafri , Seyed Mokhtar Esmaeilnejad-Ganji *
, Rahmatollah Jokar , Mohammad Zamani , Soraya Khafri , Seyed Mokhtar Esmaeilnejad-Ganji *
Department of Orthopedics, Babol University of Medical Sciences, Babol, Iran , smsnganji@yahoo.com
Abstract: (3590 Views)
Background: We aimed to compare the efficacy of local injection therapies for lateral epicondylitis in a Bayesian framework.
Methods: We searched the Embase, PubMed, Cochrane Central Register of Controlled Trials, Web of Science, Scopus, and ProQuest, for randomized controlled trials published from inception to February 2021 in any languages. The injection therapies included corticosteroids (CSs), autologous blood (AB), botulinum toxin (BT), and platelet-rich plasma (PRP). Placebo was the reference group for comparison. The study outcomes were pain, function, and strength, at 1, 3 and 6 months after injection.
Results: Thirty-one trials were finally included in this network meta-analysis, comprising 1,948 patients. In the first month of treatment, CS and BT were more efficacious than placebo in terms of pain reduction, and CS was superior to BT. In the same follow-up time, CS was also superior to placebo in terms of functional improvement. In the third month of treatment, BT was the only intervention that was more efficient than placebo in pain relief. With regard to functional improvement, none of the treatments significantly had a higher effectiveness than placebo in the same period. Moreover, no therapies were found to be more efficient than placebo in the sixth month of treatment in terms of any study outcomes. In addition, we did not identify an intervention superior to placebo regarding strength improvement outcome in any times of follow-up.
Conclusions: CSs and BT are efficient in improving clinical outcomes of lateral epicondylitis in the short term. Also, the efficacy of CSs seems to be greater than BT. On the other hand, AB and PRP were not significantly more efficient than placebo in any times of follow-up.
Methods: We searched the Embase, PubMed, Cochrane Central Register of Controlled Trials, Web of Science, Scopus, and ProQuest, for randomized controlled trials published from inception to February 2021 in any languages. The injection therapies included corticosteroids (CSs), autologous blood (AB), botulinum toxin (BT), and platelet-rich plasma (PRP). Placebo was the reference group for comparison. The study outcomes were pain, function, and strength, at 1, 3 and 6 months after injection.
Results: Thirty-one trials were finally included in this network meta-analysis, comprising 1,948 patients. In the first month of treatment, CS and BT were more efficacious than placebo in terms of pain reduction, and CS was superior to BT. In the same follow-up time, CS was also superior to placebo in terms of functional improvement. In the third month of treatment, BT was the only intervention that was more efficient than placebo in pain relief. With regard to functional improvement, none of the treatments significantly had a higher effectiveness than placebo in the same period. Moreover, no therapies were found to be more efficient than placebo in the sixth month of treatment in terms of any study outcomes. In addition, we did not identify an intervention superior to placebo regarding strength improvement outcome in any times of follow-up.
Conclusions: CSs and BT are efficient in improving clinical outcomes of lateral epicondylitis in the short term. Also, the efficacy of CSs seems to be greater than BT. On the other hand, AB and PRP were not significantly more efficient than placebo in any times of follow-up.
Keywords: Lateral epicondylitis, Tennis elbow, Injection therapies, Systematic review, Network meta-analysis
Type of Study: Review Article |
Subject:
Orthopedy
Received: 2021/05/12 | Accepted: 2021/08/8 | Published: 2022/02/21
Received: 2021/05/12 | Accepted: 2021/08/8 | Published: 2022/02/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
